Transferable cell-secreted extracellular matrices enhance osteogenic differentiation.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Cell Biology

Background:

• Synthetic biomaterials lack bioactivity and struggle to direct cell fate.
• Coating inert materials with cell-derived decellularized matrices (DMs) enhances bioactivity.
• Current methods require matrix deposition directly on the target biomaterial.

Purpose of the Study:

• To investigate if DMs created in monolayer culture can be collected and transferred to a secondary substrate while retaining their instructive potential.
• To assess the efficacy of transferred decellularized matrices (tDMs) in promoting osteogenic differentiation of human mesenchymal stem cells (hMSCs).

Main Methods:

• Human mesenchymal stem cells (hMSCs) cultured on tissue culture plastic (TCP) to create osteogenic DMs.
• Collection, homogenization, and transfer of DMs to a secondary culture surface, creating tDMs.
• Quantification of hMSC osteogenic differentiation markers (gene expression, alkaline phosphatase, calcium deposition) on DMs, tDMs, and TCP.

Main Results:

• hMSCs cultured on DMs and tDMs showed significantly higher osteogenic differentiation markers compared to cells on TCP.
• The osteogenic response to tDMs was dose-dependent.
• Reduced ERK phosphorylation and a potential role for integrin α2β1 were observed in hMSCs on tDMs.

Conclusions:

• Cell-derived matrix coatings can be effectively transferred to secondary substrates, retaining their ability to instruct cell phenotype.
• Transferred decellularized matrices (tDMs) offer a novel approach for developing hybrid biomaterials.
• This method mimics cell-extracellular matrix interactions for enhanced biomaterial design.